These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18350361)

  • 21. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis.
    Saindane AM; Law M; Ge Y; Johnson G; Babb JS; Grossman RI
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):767-72. PubMed ID: 17416836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
    BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R; Dwyer MG; Hussein S; Carl E; Kennedy C; Andrews M; Hojnacki D; Heininen-Brown M; Willis L; Cherneva M; Bergsland N; Weinstock-Guttman B
    Mult Scler; 2012 Aug; 18(8):1125-34. PubMed ID: 22194217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DTI parameter optimisation for acquisition at 1.5T: SNR analysis and clinical application.
    Laganà M; Rovaris M; Ceccarelli A; Venturelli C; Marini S; Baselli G
    Comput Intell Neurosci; 2010; 2010():254032. PubMed ID: 20069121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-oriented analysis in vivo using diffusion tensor imaging for normal-appearing brain tissue in multiple sclerosis.
    Terajima K; Matsuzawa H; Tanaka K; Nishizawa M; Nakada T
    Neuroimage; 2007 Oct; 37(4):1278-85. PubMed ID: 17689265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of callosal abnormalities in relapsing-remitting multiple sclerosis using diffusion tensor imaging: A systemic review and meta-analysis.
    Xu L; Chang SH; Yang L; Zhang LJ
    Clin Neurol Neurosurg; 2021 Feb; 201():106442. PubMed ID: 33373835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.
    Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML
    Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
    Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
    Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
    J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord.
    Hesseltine SM; Law M; Babb J; Rad M; Lopez S; Ge Y; Johnson G; Grossman RI
    AJNR Am J Neuroradiol; 2006; 27(6):1189-93. PubMed ID: 16775261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter.
    Cassol E; Ranjeva JP; Ibarrola D; Mékies C; Manelfe C; Clanet M; Berry I
    Mult Scler; 2004 Apr; 10(2):188-96. PubMed ID: 15124766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.
    Yu CS; Lin FC; Li KC; Jiang TZ; Zhu CZ; Qin W; Sun H; Chan P
    AJNR Am J Neuroradiol; 2006 May; 27(5):1009-15. PubMed ID: 16687534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X; Tench CR; Morgan PS; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.
    Arnold DL; Calabresi PA; Kieseier BC; Liu S; You X; Fiore D; Hung S
    BMC Neurol; 2017 Feb; 17(1):29. PubMed ID: 28183276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White matter microstructural alterations in clinically isolated syndrome and multiple sclerosis.
    Huang J; Liu Y; Zhao T; Shu N; Duan Y; Ren Z; Sun Z; Liu Z; Chen H; Dong H; Li K
    J Clin Neurosci; 2018 Jul; 53():27-33. PubMed ID: 29754967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR study.
    Rocca MA; Iannucci G; Rovaris M; Comi G; Filippi M
    J Neurol; 2003 Apr; 250(4):456-60. PubMed ID: 12700912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
    Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
    Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion tensor MR imaging evaluation of the corpus callosum of patients with multiple sclerosis.
    Rueda F; Hygino LC; Domingues RC; Vasconcelos CC; Papais-Alvarenga RM; Gasparetto EL
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):449-53. PubMed ID: 18813697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
    Gasperini C; Paolillo A; Giugni E; Galgani S; Bagnato F; Mainero C; Onesti E; Bastianello S; Pozzilli C
    Mult Scler; 2002 Apr; 8(2):119-23. PubMed ID: 11990868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.